Springer Nature
Browse
13195_2020_607_MOESM1_ESM.docx (241.34 kB)

Additional file 1 of Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer’s disease and type 2 diabetes

Download (241.34 kB)
journal contribution
posted on 2020-04-08, 09:05 authored by Carmen Hierro-Bujalance, Carmen Infante-Garcia, Angel del Marco, Marta Herrera, Maria Jose Carranza-Naval, Javier Suarez, Pilar Alves-Martinez, Simon Lubian-Lopez, Monica Garcia-Alloza
Additional file 1: Figure 5. Tau pathology is reduced in db/db mice after EMP treatment.

Funding

Programa Estatal de I+D+I orientada a los Retos de la Sociedad , financed by the Agencia Estatal de Investigación (AEI) and the Fondo Europeo de Desarrollo Regional (FEDER), Ministerio de Ciencia, Innovación y Universidades. Explora Ciencia. Ministerio de Ciencia, Innovación y Universidades. Subvención para la financiación de la investigación y la innovación biomédica y en ciencias de la salud en el marco de la iniciativa territorial integrada 2014-2020 para la provincia de Cádiz. Consejeria de Salud. Junta de Andalucia. Union Europea, finance Predoctoral fellowship. University of Cadiz. RECOGNISED is funded by the European Commission within the Programme of Horizon 2020

History

Usage metrics

    Alzheimer's Research & Therapy

    Categories

    Keywords

    Alzheimer’s diseaseType 2 diabetesAmyloid-βHemorrhageMicrogliaTauCognitionEmpagliflozin

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC